|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Net income/(loss) | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Premium amortization and (discount accretion), net | |||||
| Accretion of deferred commitment fees | |||||
| Amortization of deferred financing costs | |||||
| Share-based compensation | |||||
| Realized (gain)/loss on extinguishment of debt | |||||
| Realized (gain)/loss on swap terminations | |||||
| Realized (gain)/loss on sale of available for sale securities, measured at fair value | |||||
| Realized (gain)/loss on sale of commercial mortgage loans, held for sale, measured at fair value | |||||
| Realized (gain)/loss on sale of commercial mortgage loans, held for sale | |||||
| Realized (gain)/loss on sale of commercial mortgage loans, held for investment | |||||
| Unrealized (gain)/loss on commercial mortgage loans, held for sale, measured at fair value | |||||
| (Income)/loss from equity method investments | |||||
| Unrealized (gain)/losses on derivative instruments | |||||
| (Gain)/loss on other real estate investments | |||||
| Trading (gain)/loss | |||||
| Depreciation and amortization | |||||
| Straight line rental income | |||||
| Provision/(benefit) for credit losses | |||||
| Origination of commercial mortgage loans, held for sale, measured at fair value | |||||
| Proceeds from sale or repayment of commercial mortgage loans, held for sale, measured at fair value | |||||
| Severance and deferred compensation | |||||
| Origination and purchase of commercial mortgage loans, held for sale | |||||
| Proceeds from sale of commercial mortgage loans, held for sale | |||||
| Distributions from equity method investments | |||||
| MSR impairment and amortization | |||||
| Mortgage banking activities | |||||
| Changes in assets and liabilities: | |||||
| Accrued interest receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Due to affiliates | |||||
| Interest payable | |||||
| Accrued compensation | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash acquired through merger | |||||
| Origination and purchase of commercial mortgage loans, held for investment | |||||
| Principal repayments received on commercial mortgage loans, held for investment | |||||
| Principal repayments received on commercial mortgage loans, held for sale, measured at fair value | |||||
| Purchase of equity method investments | |||||
| Distributions from equity method investments | |||||
| Proceeds from sale of real estate owned, held for sale | |||||
| Purchase of real estate owned and capital expenditures | |||||
| Proceeds from sale of commercial mortgage loans, held for investment | |||||
| Purchase of NewPoint Holdings JV LLC | |||||
| Payment of software development costs | |||||
| Purchase of real estate securities, available for sale | |||||
| Proceeds from sale or paydown of real estate securities, available for sale | |||||
| Purchases of investment securities, held to maturity | |||||
| Proceeds from sale of investment securities, held to maturity | |||||
| Principal collateral on mortgage investments | |||||
| Proceeds from sale/(purchase) of derivative instruments | |||||
| Net cash (used in)/provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Cash consideration paid in merger | |||||
| Proceeds from issuances of redeemable convertible preferred stock | |||||
| Payments for common stock repurchases | |||||
| Shares canceled for tax withholding on vested equity awards | |||||
| Payments of offering costs | |||||
| Borrowings on collateralized loan obligations | |||||
| Repayments of collateralized loan obligations | |||||
| Borrowings on repurchase agreements and revolving credit facilities - commercial mortgage loans | |||||
| Repayments of repurchase agreements and revolving credit facilities - commercial mortgage loans | |||||
| Borrowings on repurchase agreements - real estate securities | |||||
| Repayments of repurchase agreements - real estate securities | |||||
| Net borrowings (paydowns) on repurchase agreements - real estate securities, less than 90 days maturity | |||||
| Borrowings on other financings | |||||
| Repayments on other financings | |||||
| Borrowings on unsecured debt | |||||
| Repayments of unsecured debt | |||||
| Borrowing on mortgage note payable | |||||
| Payments of deferred financing costs | |||||
| Cash collateral received on interest rate swaps | |||||
| Proceeds from interest rate swap settlements | |||||
| Distributions to non-controlling interest | |||||
| Contributions from non-controlling interest | |||||
| Distributions paid to common and preferred shareholders | |||||
| Net cash used in financing activities: | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash payments for income taxes | |||||
| Cash payments for interest | |||||
| Supplemental disclosures of non-cash flow information: | |||||
| Common stock issued through distribution reinvestment plan | |||||
| Distribution payable | |||||
| Loans transferred from commercial mortgage loans, held for investment to commercial mortgage loans, held for sale | |||||
| Loans transferred from commercial mortgage loans, held for investment to real estate owned, held for sale | |||||
| Modification accounted for as repayment and new loan | |||||
| Seller-based financing on sales of real estate owned, held for sale | |||||
| Reclassification of real estate owned assets held for investment to held for sale | |||||
| Reclassification of real estate owned liabilities held for investment to held for sale | |||||
| Conversion of preferred stock to common stock | |||||
| Conversion of Preferred Stock to Common Stock | |||||
| Issuances of common stock due to merger | |||||
| Issuances of Series E preferred stock due to merger | |||||
| Series E Preferred Stock | |||||
| Unsecured debt assumed due to merger | |||||
| Exchange of preferred stock | |||||
| Reconciliation of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents, beginning of period | |||||
| Restricted cash, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Restricted cash, end of period | |||||
Loading...
